These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Modification of lipid structure of cellular membrane in patients with ischemic heart disease with various extent of involvement of coronary vascular bed]. Vasil'ev AP; Senatorov IuN; Strel'tsova NN Kardiologiia; 2005; 45(2):53-4. PubMed ID: 15798707 [No Abstract] [Full Text] [Related]
28. S-allylcysteine inhibits circulatory lipid peroxidation and promotes antioxidants in N-nitrosodiethylamine-induced carcinogenesis. Sundaresan S; Subramanian P Pol J Pharmacol; 2003; 55(1):37-42. PubMed ID: 12856824 [TBL] [Abstract][Full Text] [Related]
29. [The effect of histochrome on the lipid peroxidation indices during the surgical treatment of patients with ischemic heart disease of different functional classes]. Afanas'ev SA; Lasukova TV; Cherniavskiĭ AM; Vecherskiĭ IuIu; Ponomarenko IV Eksp Klin Farmakol; 1999; 62(6):32-4. PubMed ID: 10650524 [TBL] [Abstract][Full Text] [Related]
30. Lipid peroxidation in experimental ischemia of the brain. Fedorova TN; Boldyrev AA; Gannushkina IV Biochemistry (Mosc); 1999 Jan; 64(1):75-9. PubMed ID: 9986916 [TBL] [Abstract][Full Text] [Related]
31. [The level of lipid peroxidation products and the parameters of antioxidative defense in the expired air condensate in patients with respiratory tuberculosis]. Khyshiktuev BS; Baĭke EE Probl Tuberk Bolezn Legk; 2004; (9):39-41. PubMed ID: 15532467 [TBL] [Abstract][Full Text] [Related]
32. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy. Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807 [TBL] [Abstract][Full Text] [Related]
33. [Changes in lipid peroxidation and the antioxidant system under conditions of additional respiratory resistance]. Bialovskiĭ IuIu; Morozov VN Fiziol Cheloveka; 1999; 25(5):127-9. PubMed ID: 10570894 [No Abstract] [Full Text] [Related]
34. Application of high-dose propofol during ischemia improves postischemic function of rat hearts: effects on tissue antioxidant capacity. Xia Z; Godin DV; Ansley DM Can J Physiol Pharmacol; 2004 Oct; 82(10):919-26. PubMed ID: 15573153 [TBL] [Abstract][Full Text] [Related]
35. [Blood lipids, lipid peroxidation and the effect on them of antianginal preparations in ischemic heart disease patients]. Serkova VK; Zhebel' VN; Filenko LV; Savitskaia EA Eksp Klin Farmakol; 1998; 61(2):75-8. PubMed ID: 9621182 [TBL] [Abstract][Full Text] [Related]
36. [Correction of free radical processes in patients with ischemic heart disease using bicycle exercise with free choice of load]. Chursina TV; Shcherbatykh SI Vopr Kurortol Fizioter Lech Fiz Kult; 2006; (6):15-7. PubMed ID: 17201215 [TBL] [Abstract][Full Text] [Related]
37. [Risk factors of ischemic heart disease and lipid metabolism in cardiorespiratory diseases]. Avdeeva EV; Koval'skaia EA; Vostrikova OG Klin Med (Mosk); 2000; 78(3):25-8. PubMed ID: 10790960 [TBL] [Abstract][Full Text] [Related]
38. Oxidative stress, antioxidant status and lipid profile in ischemic heart disease patients from western region of Nepal. Maharjan BR; Jha JC; Adhikari D; Akila ; Risal S; Alurkar VM; Singh PP Nepal Med Coll J; 2008 Mar; 10(1):20-4. PubMed ID: 18700625 [TBL] [Abstract][Full Text] [Related]
39. [Elevated selenium glutathione peroxidase activity in blood from patients with ischemic heart disease during treatment with selenium-containing antioxidant preparation Adrusen zinco]. Kaminnyĭ AI; Tutunov VS; Kaminnaia BI; Tikhaze AK; Lankin VZ Biull Eksp Biol Med; 2000 Mar; 129(3):277-9. PubMed ID: 10776564 [No Abstract] [Full Text] [Related]
40. [Effect of emoxypine on myocardial electrical instability and homeostasis parameters in patients with acute disturbance of cerebrovascular circulation]. Stoliarova VV Eksp Klin Farmakol; 2002; 65(3):13-5. PubMed ID: 12227086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]